FDA clears bioMerieux's MRSA test

05/25/2011 | MedCityNews.com

The FDA has granted bioMerieux 510(k) clearance to market NucliSENS EasyQ MRSA, a molecular test that can spot seven types of methicillin-resistant Staphylococcus aureus. The test can process up to 46 samples and generate results in three hours.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President - Government Products
Health Alliance Plan
Detroit, MI
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC